Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

GoTo gets $1.3bn in pre-IPO funding

Google and Tencent returned to reinvest in e-commerce and on-demand services group GoTo as it prepares to go public at a valuation of up to $30bn.


Nov 11, 2021

Daily deal net: November 11, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 11, 2021

Nykaa nabs $721m in initial public offering

The Max Group and TVS-backed fashion and beauty marketplace operator has listed on the BSE and NSE and has achieved a market cap of $13.5bn.

Nov 11, 2021

Braze aims for $402m in its IPO

The Citi-backed customer engagement platform developer has set terms for an initial public offering which could top $400m.

Nov 11, 2021

Alcon advances to $475m Ivantis acquisition

Novartis eyecare subsidiary Alcon has agreed to acquire the Institut Mérieux, Ascension Health and MemorialCare Health System-backed MIGS technology provider.

Nov 11, 2021

Entrada Therapeutics enters Nasdaq

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Nov 11, 2021

Neo4j's series F graph reaches $390m

The Alphabet and DTCP-backed graph software provider added $65m to its latest round, hiking its overall funding to about $580m.

Nov 11, 2021

Autobrains authorises $101m series C round

BMW, Continental, Knorr-Bremse and VinFast backed the autonomous perception technology developer, which traces its roots to Technion.

Nov 11, 2021

Workato flows in $200m in funding

The Salesforce, Workday and ServiceNow-backed software integration provider raised the sries E financing at a $5.7bn valuation.

Nov 11, 2021

Alchemy manifests $250m in funding

The Stanford-backed blockchain development platform increased its valuation to $3.5bn in the series C round.

Nov 11, 2021

Arbor Bio harbours $215m

Vertex Pharmaceuticals and Illumina Ventures both contributed to a round that increased the genetic therapeutics developer's total funding to over $300m.

Nov 11, 2021

Egle Therapeutics lands series A funding

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.

Nov 11, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here